Results for "consumer data right"
681-690 of 830 results for 'consumer data right'
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
Vietnam's new Land Law offers project developers more certainty and new complexities
Extensive changes to the Land Law are set to align the legal framework to acquire land more closely with practical realities, particularly for energy and infrastructure project developers. ...
ASIC ramps up greenwashing-related regulatory interventions, targeting managed funds and ASX listed entities
ASIC's latest report, ASIC's recent greenwashing interventions (the Report), outlines its recent surveillance activities and regulatory interventions to tackle misleading marketing and greenwashing. ...
ASIC's New Document Production Guidelines
ASIC has released its new Document Production Guidelines, which govern how it expects electronic and hard copy records to be produced in response to compulsory notices. ...
What does the change of government mean for Queensland's energy and resources sector?
With the results of the Queensland election having now been declared and the Labor Party invited to form government with the support of an independent Partner Ben Zillmann Managing Associate John Hedge and Associate Andrea Moffatt look at the key policies announced by Labor before the election that ...
FIRB changes to note from 1 July 2023
In this Insight, we outline and comment on the New Register and corresponding reporting obligations. ...
Revised Banking Code of Practice, innovation at the ASX and other corporate law developments
Revised Banking Code of Practice; innovation at the ASX; and other corporate law developments. ...
Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...
The pitfalls of pre-emptive rights
In this Insight, we consider an alternative approach that may better balance the rights of selling and non-selling investors where a pre-emptive right remains appropriate. ...